Full Text (PDF)
Original Article

Detection of T cell in Hodgkin’s Lymphoma before and after of BCG Administration

Vandana Shrivastava , Vandana Shrivastava , R.K. Bhatnagar

Author Information

Licence:




Indian Journal of Pathology: Research and Practice 1(2):p 81-85, May-Aug 2012. | DOI:

How Cite This Article:


Timeline

Received : N/A         Accepted : N/A          Published : N/A

Abstract

BCG is presently most studied immunostimulating agent which is able to stimulate delayed type of hypersesitivity (DTH) reaction by activating macrophages (Florentin etal 1976) we have taken diagnosed cases of HD (Hodgkin disease), patient from cancer hospital and research institute Gwalior. The studies are carried under the supervision of cancer specialist and clinician for correlation of Results. The beneficial effect was evaluated by observing improved clinical responses with regression of tumor and increase of life span of these patients. These patients were given BCG immunotherapy along with definitive therapy in various combinations. Therefore this study has been under taken with the aim and objectives. 1. To study of immunostimulatory effect of BCG in cases of Hodgkins lymphoma. 2. To evaluate immunotherapy of HD in correlation with clinical stages of disease.

Key words: (HI) Hodgkin’s lymphoma; BCG (Bacillus calmette Guerin).  


References

No records found.


About this article


Cite this article


Licence:




Received Accepted Published
N/A N/A N/A

DOI:

Keywords


Article Level Metrics

Last Updated

Sunday 12 July 2026, 13:52:42 (IST)


2018

Accesses

3
434
00

Citations


NA
NA
NA

Download citation


Article Keywords


Keyword Highlighting

Highlight selected keywords in the article text.


Timeline


Received N/A
Accepted N/A
Published N/A

licence



Access this article



Share